Showing results (61-70 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|August 12, 2006
Pharmacokinetic changes of ipriflavone in rats with acute renal failure induced by uranyl nitrateHye J Chung, Myung G LeeBiopharmaceutics & Drug Disposition|April 6, 2007
In Vitro and In Vivo pharmacokinetic studies of bulaquine (analogue of primaquine), a novel antirelapse antimalarial, in rat, rabbit and monkey--highlighting species similarities and differencesNitin Mehrotra, Jawahar Lal, Sunil Kumar Puri, et al.Biopharmaceutics & Drug Disposition|September 1, 2006
Drug disposition in three dimensions: an update on stereoselectivity in pharmacokineticsDion R BrocksBiopharmaceutics & Drug Disposition|September 1, 2006
Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomesAmit S Kalgutkar, Heather L Hatch, Frederick Kosea, et al.Biopharmaceutics & Drug Disposition|June 11, 2020
Preliminary physiologically based pharmacokinetic modeling of renally cleared drugs in Chinese pregnant womenLing Song, Zhiheng Yu, Yifan Xu, et al.Biopharmaceutics & Drug Disposition|May 1, 1988
Pharmacokinetics of caffeine in breast milk and plasma after single oral administration of caffeine to lactating mothersS Stavchansky, A Combs, R Sagraves, et al.Biopharmaceutics & Drug Disposition|July 1, 1985
Pharmacokinetics of theophylline in protein-calorie malnutritionD JungBiopharmaceutics & Drug Disposition|May 31, 2020
Concomitant lansoprazole ameliorates cisplatin-induced nephrotoxicity by inhibiting renal organic cation transporter 2 in ratsShun-Ichi Hiramatsu, Kenji Ikemura, Yutaka Fujisawa, et al.Biopharmaceutics & Drug Disposition|May 22, 2020
Inhibition of human UDP-glucuronosyltransferase enzymes by midostaurin and ruxolitinib: implications for drug-drug interactionsZhe Wang, Xiaoyu Wang, Yaqin Jia, et al.Biopharmaceutics & Drug Disposition|March 1, 1987
Single intravenous dose and steady-state oral dose pharmacokinetics of nicardipine in healthy subjectsJ G Wagner, T L Ling, E J Mroszczak, et al.Pageof 214